TET2 and myeloproliferative neoplasm: Previous studies have shown that Jak2V617F-mutant disease is initiated and propagated in the long-term hematopoietic stem cell (LT-HSC) (13), and coexpression of the Jak2V617F allele with loss of Tet2 manifests a more severe MPN phenotype (14).